
  
    
      
        Background_NNP
        The_DT expression_NN "_'' first_JJ pass_NN metabolism_NN "_'' (_( FPM_NNP )_) refers_VBZ to_TO
        the_DT metabolism_NN that_IN an_DT ingested_JJ compound_NN undergoes_NNS in_IN its_PRP$
        passage_NN through_IN the_DT gut_NN and_CC liver_NN before_IN reaching_VBG the_DT
        systemic_JJ circulation_NN ._. It_PRP is_VBZ a_DT useful_JJ concept_NN for_IN a_DT drug_NN
        because_IN it_PRP provides_VBZ information_NN about_IN the_DT relative_JJ
        therapeutic_JJ effect_NN of_IN an_DT orally_RB administered_VBN drug_NN relative_JJ
        to_TO its_PRP$ intravenous_JJ administration_NN (_( IV_NNP )_) ._. The_DT standard_JJ
        approach_NN to_TO quantitate_NN FPM_NNP is_VBZ to_TO compare_VB the_DT area_NN under_IN the_DT
        curve_NN (_( AUC_NNP )_) for_IN equal_JJ IV_NNP and_CC oral_JJ doses_NNS ._. The_DT fractional_JJ FPM_NNP
        is_VBZ then_RB defined_VBN as_IN the_DT fractional_JJ difference_NN in_IN these_DT two_CD
        areas_NNS :_:
        
        The_DT mathematical_JJ basis_NN of_IN this_DT definition_NN is_VBZ based_VBN on_IN
        the_DT following_JJ arguments_NNS :_: Given_VBN some_DT time_NN dependent_JJ input_NN to_TO
        the_DT systemic_JJ compartment_NN (_( I_NN (_( t_NN )_) )_) ,_, and_CC some_DT removal_NN rate_NN from_IN
        the_DT systemic_JJ compartment_NN (_( Q_NNP (_( t_NN )_) )_) ,_, the_DT integral_JJ over_IN all_DT time_NN
        of_IN these_DT two_CD rates_NNS must_MD be_VB equal_JJ :_:
        
        If_IN the_DT removal_NN rate_NN has_VBZ a_DT linear_JJ dependence_NN on_IN
        concentration_NN (_( Q_NNP (_( t_NN )_) =_SYM KC_NNP (_( t_NN )_) )_) then_RB this_DT total_JJ input_NN can_MD be_VB
        related_VBN to_TO the_DT AUC_NNP :_:
        
        Since_IN the_DT total_JJ input_NN to_TO the_DT systemic_JJ compartment_NN is_VBZ
        proportional_JJ to_TO the_DT AUC_NNP (_( eq_NN ._. 3_LS )_) ,_, the_DT fractional_JJ difference_NN
        in_IN the_DT AUC_NNP for_IN an_DT oral_JJ and_CC IV_NNP dose_NN (_( eq_NN 1_LS )_) is_VBZ a_DT measure_NN of_IN
        the_DT amount_NN of_IN the_DT oral_JJ drug_NN that_IN never_RB reached_VBD the_DT systemic_JJ
        compartment_NN because_IN of_IN FPM_NNP ._.
        This_DT standard_JJ operational_JJ definition_NN of_IN FPM_NNP (_( eq_NN ._. 1_LS )_) is_VBZ
        crucially_RB dependent_JJ on_IN the_DT assumption_NN that_IN the_DT removal_NN rate_NN
        is_VBZ linear_JJ ._. If_IN this_DT assumption_NN is_VBZ invalid_JJ ,_, then_RB use_NN of_IN this_DT
        definition_NN can_MD return_VB very_RB misleading_JJ results_NNS ._. A_DT recent_JJ
        review_NN has_VBZ described_VBN the_DT confusion_NN that_WDT has_VBZ resulted_VBN from_IN
        applying_VBG this_DT definition_NN to_TO human_JJ ethanol_NN pharmacokinetics_NNS ,_,
        a_DT compound_NN that_WDT has_VBZ extremely_RB non-linear_JJ liver_NN metabolism_NN [_NN
        1_CD ]_NN ._.
        For_IN the_DT non-linear_JJ case_NN ,_, the_DT intuitive_JJ idea_NN that_IN FPM_NNP is_VBZ
        equal_JJ to_TO the_DT fraction_NN of_IN the_DT absorbed_VBN drug_NN that_WDT is_VBZ
        metabolized_VBN in_IN its_PRP$ first_JJ pass_NN through_IN the_DT liver_NN is_VBZ no_DT
        longer_RB valid_JJ [_NN 2_CD ]_NN ._. Consider_VB the_DT case_NN where_WRB GI_NNP absorption_NN
        is_VBZ occurring_VBG at_IN a_DT time_NN when_WRB the_DT systemic_JJ drug_NN concentration_NN
        is_VBZ so_RB high_JJ that_IN the_DT liver_NN metabolism_NN is_VBZ completely_RB
        saturated_VBN and_CC the_DT metabolic_JJ rate_NN is_VBZ constant_JJ ,_, independent_JJ
        of_IN concentration_NN ._. Clearly_RB ,_, at_IN this_DT time_NN ,_, the_DT rate_NN of_IN drug_NN
        metabolism_NN for_IN an_DT oral_JJ input_NN must_MD be_VB identical_JJ to_TO that_DT for_IN
        an_DT IV_NNP input_NN so_IN that_IN FPM_NNP must_MD be_VB zero_CD ,_, even_RB though_IN a_DT large_JJ
        fraction_NN of_IN the_DT absorbed_VBN drug_NN may_MD be_VB metabolized_VBN in_IN its_PRP$
        first_JJ pass_NN through_IN the_DT liver_NN ._. This_DT metabolized_VBN GI_NNP component_NN
        is_VBZ simply_RB displacing_NN systemic_JJ drug_NN that_WDT would_MD otherwise_RB
        have_VB been_VBN metabolized_VBN ._.
        In_IN order_NN to_TO avoid_VB these_DT problems_NNS ,_, Lieber_NNP and_CC colleagues_NNS
        [_NN 3_CD ]_NN introduced_VBD a_DT new_JJ definition_NN of_IN FPM_NNP ,_, based_VBN on_IN
        estimating_VBG the_DT "_'' Peripheral_NNP Availability_NNP "_'' (_( PA_NNP )_) of_IN ethanol_NN ._.
        The_DT PA_NNP is_VBZ defined_VBN as_IN the_DT total_JJ amount_NN of_IN ethanol_NN that_WDT
        reaches_VBZ the_DT systemic_JJ circulation_NN ._. Gentry_NNP et_CC al_NN ._. [_NN 3_CD ]_NN
        estimated_VBD the_DT value_NN of_IN PA_NNP by_IN assuming_VBG that_IN the_DT tail_NN of_IN the_DT
        IV_NNP ethanol_NN venous_JJ concentration_NN curve_NN can_MD be_VB approximated_JJ
        by_IN a_DT one_CD compartment_NN model_NN in_IN which_WDT the_DT ethanol_NN rate_NN of_IN
        metabolism_NN (_( M_NNP )_) was_VBD defined_VBN by_IN a_DT Michaelis-_NNP Menten_NNP function_NN
        (_( M_NNP =_SYM VmC_NNP /_NN (_( Km_NNP +_NN C_NNP )_) )_) ._. The_DT values_NNS of_IN Vm_NNP and_CC Km_NNP are_VBP found_VBN by_IN
        curve_NN fitting_JJ ,_, and_CC then_RB PA_NNP is_VBZ defined_VBN as_IN the_DT integral_JJ of_IN M_NNP
        from_IN time_NN 0_CD to_TO a_DT long_JJ time_NN when_WRB no_DT ethanol_NN is_VBZ present_JJ ._.
        Thus_RB ,_, PA_NNP is_VBZ defined_VBN as_IN the_DT total_JJ amount_NN of_IN ethanol_NN that_WDT was_VBD
        metabolized_VBN from_IN the_DT systemic_JJ circulation_NN ._. The_DT FPM_NNP is_VBZ then_RB
        defined_VBN as_IN the_DT difference_NN between_IN the_DT PA_NNP for_IN an_DT IV_NNP infusion_NN
        and_CC the_DT PA_NNP for_IN the_DT oral_JJ intake_NN of_IN an_DT identical_JJ dose_NN ._. This_DT
        one_CD compartment_NN definition_NN of_IN FPM_NNP has_VBZ become_VBN the_DT standard_JJ
        definition_NN in_IN some_DT laboratories_NNS [_NN 4_CD ]_NN ._.
        This_DT definition_NN of_IN FPM_NNP of_IN Gentry_NNP et_CC al_NN ._. [_NN 3_CD ]_NN is_VBZ
        inaccurate_JJ because_IN it_PRP is_VBZ a_DT poor_JJ approximation_NN to_TO treat_VB
        ethanol_NN metabolism_NN as_IN a_DT one_CD compartment_NN system_NN (_( see_VB below_IN )_) ._.
        Levitt_NNP and_CC Levitt_NNP [_NN 2_CD ]_NN described_VBD an_DT approach_NN to_TO estimate_VB
        PA_NNP using_VBG a_DT two_CD compartment_NN model_NN ._. They_PRP distinguished_VBD the_DT
        liver_NN ethanol_NN that_WDT came_VBD directly_RB from_IN the_DT GI_NNP tract_NN from_IN the_DT
        recirculating_VBG ethanol_NN ,_, and_CC derived_VBD an_DT accurate_JJ
        approximation_NN for_IN this_DT recirculating_VBG component_NN ._. This_DT 2_CD
        compartment_NN approach_NN provides_VBZ a_DT significantly_RB more_RBR accurate_JJ
        (_( and_CC smaller_JJR )_) estimate_NN of_IN FPM_NNP than_IN the_DT one_CD compartment_NN
        model_NN ._.
        The_DT 2_CD compartment_NN model_NN still_RB makes_VBZ some_DT simplifying_VBG
        assumptions_NNS ._. These_DT assumptions_NNS are_VBP eliminated_VBN in_IN PKQuest_NNP [_NN
        5_CD ]_NN ,_, a_DT new_JJ ,_, general-purpose_JJ physiologically_RB based_VBN
        pharmacokinetic_JJ (_( PBPK_NNP )_) software_NN routine_JJ ._. The_DT approach_NN used_VBN
        by_IN PKQuest_NNP is_VBZ to_TO first_JJ use_NN the_DT IV_NNP input_NN data_NNS to_TO find_VB the_DT
        PBPK_NNP parameters_NNS for_IN ethanol_NN ,_, and_CC then_RB ,_, using_VBG these_DT
        parameters_NNS ,_, solve_VB for_IN the_DT time_NN dependent_JJ IV_NNP input_NN function_NN
        that_WDT would_MD produce_VB a_DT blood_NN time_NN course_NN identical_JJ to_TO the_DT
        time_NN course_NN observed_VBD with_IN the_DT orally_RB administered_VBN drug_NN ._.
        This_DT IV_NNP input_NN function_NN is_VBZ a_DT direct_JJ measure_NN of_IN the_DT rate_NN that_IN
        the_DT oral_JJ dose_NN reaches_VBZ the_DT systemic_JJ circulation_NN ,_, i_NNP ._. e_SYM ._. the_DT
        PA_NNP ._. Using_VBG as_IN input_NN just_RB the_DT PBPK_NNP parameters_NNS and_CC the_DT blood_NN
        ethanol_NN levels_NNS produced_VBN by_IN an_DT oral_JJ dose_NN ,_, PKQuest_NNP outputs_NNS
        (_( in_IN both_DT tabular_NN and_CC graphical_JJ form_NN )_) the_DT time_NN course_NN of_IN the_DT
        intestinal_NN absorption_NN and_CC the_DT PA_NNP (_( see_VB [_NN 5_CD ]_NN for_IN the_DT
        mathematical_JJ and_CC computational_NN details_NNS )_) ._.
        The_DT difficulty_NN in_IN defining_VBG the_DT FPM_NNP of_IN ethanol_NN has_VBZ
        created_VBN a_DT controversy_NN over_IN the_DT question_NN of_IN the_DT magnitude_NN of_IN
        ethanol_NN metabolism_NN that_WDT occurs_VBZ in_IN the_DT stomach_NN before_IN
        reaching_VBG the_DT liver_NN [_NN 1_CD ]_NN ._. It_PRP has_VBZ been_VBN observed_VBN that_IN the_DT
        "_'' FPM_NNP "_'' is_VBZ significantly_RB reduced_VBN when_WRB ethanol_NN is_VBZ infused_VBN
        intraduodenally_RB compared_VBN to_TO the_DT standard_JJ oral_JJ
        administration_NN and_CC this_DT difference_NN has_VBZ been_VBN interpreted_VBN as_IN
        representing_VBG gastric_JJ mucosal_NN metabolism_NN [_NN 6_CD 7_CD 8_CD ]_NN ._.
        Clearly_RB ,_, if_IN there_EX are_VBP errors_NNS in_IN the_DT measurement_NN of_IN FPM_NNP then_RB
        this_DT estimate_NN of_IN gastric_JJ metabolism_NN may_MD be_VB spurious_JJ ._. In_IN
        addition_NN to_TO providing_VBG a_DT value_NN for_IN FPM_NNP ,_, PKQuest_NNP also_RB
        provides_VBZ a_DT direct_JJ measurement_NN of_IN the_DT rate_NN and_CC amount_NN of_IN the_DT
        orally_RB administered_VBN solute_NN that_WDT reaches_VBZ the_DT liver_NN ._. In_IN this_DT
        paper_NN ,_, PKQuest_NNP will_MD be_VB applied_VBN to_TO investigations_NNS of_IN human_JJ
        ethanol_NN pharmacokinetics_NNS ,_, providing_VBG information_NN about_IN the_DT
        FPM_NNP ;_: the_DT time_NN course_NN of_IN intestinal_NN absorption_NN ,_, and_CC the_DT
        total_JJ amount_NN of_IN ethanol_NN reaching_VBG the_DT liver_NN ._. This_DT is_VBZ the_DT
        first_JJ human_JJ PBPK_NNP model_NN for_IN ethanol_NN incorporating_VBG intestinal_NN
        absorption_NN and_CC FPM_NNP ._. Pistino_NNP and_CC Conolly_NNP [_NN 9_CD ]_NN have_VBP
        previously_RB developed_VBN a_DT rat_NN PBPK_NNP that_IN quantitated_JJ ethanol_NN
        FPM_NNP ._.
        The_DT PKQuest_NNP program_NN and_CC all_PDT the_DT examples_NNS used_VBN here_RB are_VBP
        freely_RB available_JJ on_IN the_DT WEB_NNP at_IN www_NN ._. pkquest_NN ._. com_NN ._.
      
      
        Methods_NNP
        
          PBPK_NNP program_NN and_CC its_PRP$ assumptions_NNS
          PKQuest_NNP [_NN 5_CD ]_NN was_VBD used_VBN for_IN all_PDT the_DT analysis_NN in_IN this_DT
          paper_NN ._. All_DT the_DT figures_NNS shown_VBN in_IN this_DT paper_NN are_VBP direct_JJ
          copies_NNS (_( in_IN jpeg_NN format_NN )_) of_IN standard_JJ PKQuest_NNP output_NN ._.
          PKQuest_NNP makes_VBZ several_JJ simplifying_VBG assumptions_NNS (_( see_VB [_NN 5_CD ]_NN
          for_IN details_NNS )_) ._. It_PRP is_VBZ assumed_VBN that_IN each_DT organ_NN can_MD be_VB
          modeled_VBN as_IN a_DT single_JJ well-stirred_JJ compartment_NN ._. In_IN
          addition_NN ,_, for_IN the_DT two_CD solutes_NNS investigated_VBN in_IN this_DT paper_NN
          (_( D_NNP 
          2_CD O_NNP and_CC ethanol_NN )_) it_PRP is_VBZ also_RB assumed_VBN
          that_IN the_DT blood-tissue_JJ exchange_NN is_VBZ flow_NN limited_JJ so_IN that_IN
          the_DT unbound_NN water_NN concentration_NN in_IN the_DT tissue_NN is_VBZ equal_JJ to_TO
          that_DT in_IN the_DT vein_NN leaving_VBG the_DT tissue_NN ._. This_DT is_VBZ clearly_RB an_DT
          approximation_NN and_CC effects_NNS such_JJ as_IN diffusion_NN gradients_NNS ,_,
          countercurrent_NN exchange_NN and_CC heterogeneous_JJ organ_NN blood_NN
          flows_NNS [_NN 10_CD 11_CD 12_CD ]_NN will_MD produce_VB small_JJ deviations_NNS from_IN
          this_DT assumption_NN ._.
        
        
          Standard_NNP human_JJ parameters_NNS
          The_DT PBPK_NNP parameters_NNS used_VBN here_RB are_VBP identical_JJ to_TO those_DT
          used_VBN in_IN all_PDT the_DT other_JJ applications_NNS of_IN PKQuest_NNP [_NN 5_CD 13_CD 14_CD ]_NN
          ._. The_DT procedures_NNS used_VBN for_IN choosing_VBG and_CC refining_VBG these_DT
          parameters_NNS has_VBZ been_VBN described_VBN in_IN [_NN 5_CD ]_NN ._. Table_NNP 1_CD lists_NNS the_DT
          organ_NN weights_NNS (_( Kg_NNP )_) and_CC blood_NN flows_NNS (_( liters_NNS /_NN min_NN /_NN Kg_NNP )_) for_IN
          the_DT standard_JJ 70_CD Kg_NNP human_NN ._. The_DT "_'' liver_NN "_'' flow_NN is_VBZ the_DT hepatic_JJ
          blood_NN flow_NN ;_: "_'' portal_NN "_'' refers_VBZ to_TO the_DT portal_NN vein_NN blood_NN flow_NN
          and_CC to_TO the_DT organs_NNS drained_VBN by_IN the_DT portal_NN vein_NN (_( stomach_NN ,_,
          small_JJ and_CC large_JJ intestine_NN ,_, spleen_NN and_CC pancreas_NN )_) ;_: "_'' bone_NN "_''
          refers_VBZ to_TO the_DT inert_NN component_NN of_IN bone_NN ,_, cartilage_NN etc_FW ._. in_IN
          which_WDT it_PRP is_VBZ assumed_VBN there_EX is_VBZ no_DT solute_NN distribution_NN or_CC
          blood_NN flow_NN ;_: and_CC "_'' other_JJ "_'' are_VBP all_PDT the_DT other_JJ organs_NNS with_IN a_DT
          flow_NN and_CC weight_NN adjusted_VBN to_TO account_VB for_IN the_DT total_JJ body_NN
          weight_NN (_( 70_CD Kg_NNP )_) and_CC the_DT total_JJ default_NN cardiac_JJ output_NN (_( 6_CD ._. 06_CD
          liters_NNS /_NN min_NN )_) ._. These_DT organ_NN weights_NNS are_VBP for_IN the_DT default_NN
          value_NN of_IN 20_CD %_NN body_NN fat_JJ ._. They_PRP are_VBP scaled_VBN depending_VBG on_IN the_DT
          value_NN of_IN "_'' Fat_NNP "_'' that_WDT is_VBZ input_NN ._. For_IN a_DT complete_JJ listing_NN of_IN
          all_DT parameters_NNS and_CC constants_NNS used_VBN in_IN PKQuest_NNP ,_, download_NN
          the_DT file_NN gensolve_NN ._. mws_NNS from_IN the_DT PKQuest_NNP web_NN site_NN
          www_NN ._. pkquest_NN ._. comand_NN view_NN the_DT routines_NNS "_'' standardman_NN (_( )_) "_'' and_CC
          "_'' defaultpar_NN (_( )_) "_'' ._.
        
        
          Experimental_NNP data_NNS
          The_DT D_NNP 
          2_CD O_NNP data_NNS was_VBD obtained_VBN from_IN the_DT
          measurements_NNS of_IN the_DT Schloerb_NNP et_CC al_NN ._. [_NN 15_CD ]_NN of_IN the_DT
          arterial_NN serum_NN concentration_NN after_IN a_DT 15_CD second_JJ bolus_JJ
          injection_NN ._. The_DT results_NNS are_VBP for_IN one_CD experiment_NN on_IN one_CD male_JJ
          subject_JJ (_( J_NNP ._. O_NNP ._. ,_, total_JJ body_NN water_NN of_IN 48_CD ._. 0_CD liters_NNS ,_, Table_NNP I_PRP [_NN
          15_CD ]_NN )_) ._. The_DT amount_NN of_IN D_NNP 
          2_CD O_NNP injected_VBD was_VBD back_RB calculated_VBN from_IN
          the_DT total_JJ body_NN water_NN and_CC the_DT concentration_NN after_IN 90_CD
          minutes_NNS when_WRB the_DT D_NNP 
          2_CD O_NNP had_VBD equilibrated_JJ ._.
          A_DT baseline_NN ethanol_NN PBPK_NNP model_NN was_VBD developed_VBN based_VBN on_IN
          the_DT careful_JJ and_CC detailed_JJ measurements_NNS of_IN Norberg_NNP et_CC al_NN ._. [_NN
          16_CD ]_NN of_IN the_DT simultaneous_JJ breath_NN and_CC venous_JJ blood_NN
          concentrations_NNS for_IN a_DT 30_CD minute_NN constant_JJ IV_NNP ethanol_NN
          infusion_NN ._. The_DT concentration_NN calculated_VBN from_IN the_DT breath_NN
          measurements_NNS was_VBD in_IN good_JJ agreement_NN with_IN the_DT direct_JJ venous_JJ
          measurements_NNS ._. The_DT breath_NN results_NNS were_VBD used_VBN here_RB since_IN
          they_PRP should_MD be_VB closer_JJR to_TO the_DT ideal_NN of_IN an_DT arterial_NN sample_NN
          then_RB the_DT venous_JJ measurements_NNS from_IN the_DT cubital_NN vein_NN ._. The_DT
          total_JJ body_NN water_NN for_IN each_DT subject_NN in_IN this_DT study_NN was_VBD
          directly_RB measured_VBN using_VBG D_NNP 
          2_CD O_NNP ._. The_DT time_NN course_NN of_IN the_DT mean_NN
          values_NNS for_IN all_DT 16_CD subjects_NNS (_( figure_NN 1_CD ,_, [_NN 16_CD ]_NN )_) was_VBD
          modeled_VBN using_VBG PKQuest_NNP ._. The_DT data_NNS of_IN DiPadova_NNP et_CC al_NN ._. [_NN 17_CD ]_NN
          was_VBD used_VBN for_IN the_DT determination_NN of_IN the_DT rate_NN of_IN absorption_NN
          of_IN oral_JJ ethanol_NN ,_, along_IN with_IN calculations_NNS of_IN the_DT PA_NNP and_CC
          FPM_NNP ._. PKQuest_NNP was_VBD applied_VBN to_TO the_DT data_NNS plotted_VBD in_IN figures_NNS
          1_CD and_CC 3_CD of_IN DiPadova_NNP et_CC al_NN ._. [_NN 17_CD ]_NN which_WDT describe_VBP the_DT mean_NN
          blood_NN ethanol_NN for_IN subjects_NNS given_VBN 0_CD ._. 15_CD g_SYM /_NN Kg_NNP body_NN weight_NN
          (_( fig_NN ._. 1_LS )_) or_CC 0_CD ._. 3_CD g_SYM /_NN Kg_NNP (_( fig_NN ._. 3_LS )_) either_CC orally_RB (_( with_IN or_CC
          without_IN a_DT breakfast_NN )_) or_CC IV_NNP on_IN alternate_JJ days_NNS ._.
          The_DT experimental_JJ data_NN points_NNS were_VBD obtained_VBN by_IN using_VBG
          UN-SCAN-IT_NNP (_( Silk_NNP Scientific_NNP Corporation_NNP )_) to_TO read_VB the_DT data_NNS
          from_IN the_DT published_VBN figures_NNS ._.
        
      
      
        Results_NNS
        
          Determination_NNP of_IN baseline_NN resting_VBG muscle_NN blood_NN
          flow_NN
          The_DT baseline_NN resting_VBG muscle_NN blood_NN flow_NN used_VBN in_IN PKQuest_NNP
          was_VBD determined_VBN by_IN fitting_JJ the_DT D_NNP 
          2_CD O_NNP data_NNS of_IN Schoerb_NNP et_CC al_NN ._. [_NN 15_CD ]_NN in_IN
          which_WDT the_DT arterial_NN D_NNP 
          2_CD O_NNP concentration_NN was_VBD measured_VBN after_IN a_DT
          15_CD second_JJ venous_JJ injection_NN of_IN D_NNP 
          2_CD O_NNP ._. As_IN described_VBD previously_RB [_NN 5_CD ]_NN ,_,
          each_DT compound_NN modeled_VBN by_IN PKQuest_NNP is_VBZ characterized_VBN by_IN a_DT
          short_JJ Maple_NNP www_NN ._. maplesoft_NN ._. comprocedure_NN that_IN lists_VBZ the_DT
          model_NN parameters_NNS that_WDT are_VBP unique_JJ for_IN that_DT solute_NN ._. The_DT
          procedure_NN for_IN D_NNP 
          2_CD O_NNP is_VBZ very_RB simple_JJ because_IN it_PRP
          corresponds_NNS to_TO the_DT default_NN case_NN so_IN that_IN very_RB few_JJ
          parameters_NNS have_VBP to_TO be_VB input_NN :_:
          d_SYM 20_CD __NN schoerb_NN :_: =_SYM proc_NN (_( )_)
          defaultpar_NN (_( )_) :_:
          Wtot_NNP :_: =_SYM 81_CD ._. 9_CD ;_:
          standardhuman_NN (_( Wtot_NNP )_) ;_:
          cunit_NN :_: =_SYM "_'' 10_CD ml_NN D_NNP 20_CD "_'' ;_: #_# 10_CD ml_NN /_NN liter_NN is_VBZ equivalent_JJ to_TO
          vol_NN %_NN
          concunit_NN [_NN artery_NN ]_NN :_: =_SYM 3_CD ;_: #_# input_NN data_NNS is_VBZ concentration_NN in_IN
          free_JJ water_NN
          ninput_NN :_: =_SYM 1_CD ;_: finput_NN [_NN 1_CD ]_NN :_:
          table_NN (_( [_NN organ_NN =_SYM vein_NN ,_, type_NN =_SYM 1_CD ,_, rate_NN =_SYM 27_CD ._. 6_CD ,_, tbeg_NN =_SYM 0_CD ,_,
          tend_VBP =_SYM ._. 25_CD ,_, csteady_NN =_SYM 0_CD ,_, padjust_NN =_SYM 0_CD ]_NN )_) ;_:
          end_NN proc_NN :_:
          The_DT published_VBN data_NN was_VBD for_IN subject_JJ JO_NNP (_( body_NN weight_NN
          81_CD ._. 9_CD Kg_NNP and_CC total_JJ body_NN water_NN =_SYM 48_CD liters_NNS )_) ._. This_DT value_NN for_IN
          total_JJ body_NN water_NN (_( 0_CD ._. 58_CD liter_NN /_NN Kg_NNP )_) corresponds_NNS to_TO a_DT body_NN
          fat_JJ fraction_NN of_IN about_IN 0_CD ._. 2_CD [_NN 18_CD ]_NN ._. ._. This_DT subject_NN was_VBD
          defined_VBN as_RB the_DT "_'' standardhuman_NN "_'' (_( Fat_NNP =_SYM 0_CD ._. 2_LS )_) ._. The_DT values_NNS of_IN
          the_DT water_NN fraction_NN parameter_NN for_IN each_DT tissue_NN compartment_NN
          in_IN PKQuest_NNP was_VBD then_RB adjusted_VBN so_IN that_IN the_DT model_NN total_JJ body_NN
          water_NN equaled_VBD this_DT measured_JJ value_NN ._. Since_IN ,_, this_DT man_NN is_VBZ the_DT
          "_'' standardhuman_NN "_'' ,_, all_PDT the_DT PBPK_NNP parameter_NN are_VBP input_NN simply_RB
          by_IN calls_VBZ to_TO the_DT "_'' defaultpar_NN (_( )_) "_'' and_CC "_'' standardhuman_NN (_( )_) "_''
          procedures_NNS ._. All_DT units_NNS in_IN PKQuest_NNP are_VBP in_IN terms_NNS of_IN liters_NNS ,_,
          Kg_NNP and_CC minutes_NNS ._. The_DT parameter_NN "_'' cunit_NN "_'' is_VBZ the_DT amount_NN unit_NN
          (_( concentration_NN =_SYM cunit_NN /_NN liter_NN )_) ._. Since_IN the_DT D_NNP 
          2_CD O_NNP concentration_NN was_VBD expressed_VBN in_IN
          vol_NN %_NN ,_, this_DT corresponds_NNS to_TO a_DT cunit_NN of_IN 10_CD ml_NN ._. The_DT only_RB
          other_JJ information_NN that_WDT is_VBZ needed_VBN is_VBZ concunit_NN [_NN artery_NN ]_NN =_SYM
          3_CD ,_, which_WDT indicates_VBZ that_IN the_DT input_NN data_NN is_VBZ the_DT arterial_NN
          free_JJ water_NN concentration_NN ._. The_DT observed_VBN equilibrium_NN
          concentration_NN was_VBD 0_CD ._. 144_CD vol_NN %_NN which_WDT corresponds_NNS to_TO a_DT total_JJ
          D_NNP 
          2_CD O_NNP dose_NN of_IN 69_CD ._. 05_CD ml_NN ,_, or_CC 276_CD ml_NN /_NN min_NN
          for_IN 0_CD ._. 25_CD minutes_NNS ,_, or_CC 27_CD ._. 6_CD units_NNS /_NN min_NN if_IN 1_CD unit_NN =_SYM 10_CD ml_NN ._.
          The_DT output_NN of_IN PKQuest_NNP for_IN this_DT data_NNS is_VBZ shown_VBN in_IN fig_NN ._.
          1_LS A_DT (_( all_DT of_IN the_DT figures_NNS in_IN this_DT paper_NN are_VBP taken_VBN unmodified_JJ
          from_IN the_DT standard_JJ output_NN of_IN PKQuest_NNP )_) ._. The_DT value_NN for_IN the_DT
          resting_VBG muscle_NN blood_NN flow_NN (_( 0_CD ._. 0266_CD Lit_NNP /_NN min_NN /_NN Kg_NNP )_) was_VBD
          determined_VBN by_IN adjusting_NN the_DT flow_NN to_TO optimize_NN the_DT fit_NN to_TO
          the_DT data_NNS using_VBG the_DT Powell_NNP minimization_NN procedure_NN of_IN
          PKQuest_NNP ._. The_DT agreement_NN between_IN the_DT PBPK_NNP prediction_NN (_( solid_JJ
          line_NN )_) and_CC the_DT experimental_JJ measurements_NNS (_( squares_NNS )_) is_VBZ very_RB
          good_JJ ._.
          This_DT agreement_NN is_VBZ sensitive_JJ to_TO the_DT value_NN used_VBN for_IN the_DT
          muscle_NN blood_NN flow_NN ._. For_IN example_NN ,_, fig_NN ._. 1_LS Bshows_NNP the_DT effect_NN
          of_IN doubling_VBG the_DT total_JJ muscle_NN blood_NN flow_NN from_IN this_DT
          default_NN ,_, best_JJS fit_VB ,_, value_NN of_IN 0_CD ._. 0266_CD to_TO 0_CD ._. 0532_CD
          liters_NNS /_NN min_NN /_NN kg_NN (_( increasing_VBG the_DT cardiac_JJ output_NN from_IN 6_CD ._. 06_CD to_TO
          6_CD ._. 93_CD liters_NNS /_NN min_NN for_IN a_DT 70_CD Kg_NNP man_NN )_) ._. Muscle_NNP blood_NN flow_NN can_MD
          vary_VB many_JJ fold_VB and_CC one_PRP would_MD expect_VB that_IN it_PRP would_MD depend_VB
          on_IN the_DT specific_JJ experimental_JJ conditions_NNS ,_, such_JJ as_IN whether_IN
          the_DT subject_NN was_VBD supine_NN or_CC ambulatory_JJ ._. In_IN any_DT case_NN ,_, muscle_NN
          blood_NN flow_NN is_VBZ routinely_RB varied_VBN when_WRB fitting_JJ data_NNS with_IN
          PKQuest_NNP ._. This_DT variation_NN may_MD have_VB some_DT physiological_JJ
          significance_NN and_CC /_NN or_CC it_PRP may_MD be_VB just_RB a_DT "_'' fudge_VB factor_NN "_'' ._.
        
        
          Standard_NNP Ethanol_NNP PBPK_NNP parameters_NNS
          The_DT recent_JJ measurements_NNS of_IN Norberg_NNP et_CC al_NN ._. [_NN 16_CD ]_NN of_IN
          the_DT time_NN course_NN of_IN ethanol_NN blood_NN levels_NNS after_IN an_DT IV_NNP input_NN
          were_VBD used_VBN to_TO determine_VB the_DT standard_JJ ethanol_NN PBPK_NNP
          parameters_NNS ._. PKQuest_NNP was_VBD used_VBN to_TO model_VB the_DT time_NN course_NN of_IN
          the_DT mean_JJ blood_NN values_NNS of_IN the_DT 16_CD subjects_NNS (_( 8_CD men_NNS ,_, 8_CD
          women_NNS )_) ._. This_DT data_NNS was_VBD expressed_VBN as_IN the_DT concentration_NN in_IN
          the_DT blood_NN in_IN units_NNS of_IN millimoles_NNS /_NN liter_NN of_IN blood_NN water_NN ._.
          Both_DT breath_NN and_CC direct_JJ venous_JJ sampling_VBG results_NNS were_VBD
          reported_VBN and_CC they_PRP were_VBD in_IN very_RB good_JJ agreement_NN ._. The_DT
          results_NNS shown_VBN in_IN fig_NN ._. 2_LS use_NN the_DT breath_NN measurements_NNS since_IN
          they_PRP should_MD be_VB closer_JJR to_TO the_DT ideal_NN of_IN an_DT arterial_NN sample_NN
          then_RB the_DT venous_JJ measurements_NNS from_IN the_DT cubital_NN vein_NN ._. The_DT
          PKQuest_NNP procedure_NN that_WDT is_VBZ used_VBN for_IN ethanol_NN is_VBZ listed_VBN
          below_IN :_:
          ethanol_NN __NN norberg_NN :_: =_SYM proc_NN (_( )_)
          defaultpar_NN (_( )_) :_:
          Wtot_NNP :_: =_SYM 80_CD ._. 0_CD ;_: #_# Arbitray_NNP since_IN ethanol_NN dose_NN is_VBZ per_IN Kg_NNP
          standardhuman_NN (_( Wtot_NNP )_) ;_:
          Fat_NNP :_: =_SYM 0_CD ._. 24_CD ;_:
          cunit_NN :_: =_SYM "_'' millimoles_NNS "_'' ;_:
          concunit_NN [_NN artery_NN ]_NN :_: =_SYM 3_CD ;_: #_# concentration_NN in_IN arterial_NN blood_NN
          water_NN
          Vm_NNP [_NN liver_NN ]_NN :_: =_SYM 2_CD ._. 1_LS :_:
          Km_NNP [_NN liver_NN ]_NN :_: =_SYM 0_CD ._. 04_CD ;_:
          fw_NN [_NN lipid_NN ]_NN :_: =_SYM 1_CD ._. 0_CD /_NN 0_CD ._. 074_CD ;_: #_# =_SYM 1_CD /_NN (_( oil-water_JJ partition_NN
          coefficient_NN for_IN ethanol_NN )_)
          ninput_NN :_: =_SYM 1_CD ;_: finput_NN [_NN 1_CD ]_NN :_:
          table_NN (_( [_NN organ_NN =_SYM vein_NN ,_, type_NN =_SYM 1_CD ,_, rate_NN =_SYM 23_CD ._. 15_CD ,_, tbeg_NN =_SYM 0_CD ,_,
          tend_VBP =_SYM 30_CD ,_, csteady_NN =_SYM 0_CD ,_, padjust_NN =_SYM 0_CD ]_NN )_) ;_:
          end_NN proc_NN ;_:
          The_DT value_NN for_IN Fat_NNP (_( fraction_NN of_IN body_NN weight_NN that_WDT is_VBZ
          fat_JJ )_) of_IN 0_CD ._. 24_CD was_VBD chosen_VBN so_IN that_IN the_DT model_NN subject_NN had_VBD a_DT
          water_NN volume_NN equal_JJ to_TO the_DT average_JJ D_NNP 
          2_CD O_NNP volume_NN of_IN distribution_NN of_IN the_DT 8_CD
          males_NNS and_CC 8_CD females_NNS in_IN the_DT study_NN (_( 44_CD ._. 5_LS liters_NNS for_IN 80_CD Kg_NNP
          human_JJ )_) ._. The_DT muscle_NN blood_NN flow_NN was_VBD the_DT same_JJ as_IN the_DT
          (_( default_NN )_) value_NN that_WDT was_VBD used_VBN in_IN fig_NN ._. 1_LS Afor_NNP the_DT D_NNP 
          2_CD O_NNP data_NNS ._. Since_IN liver_NN metabolism_NN
          accounts_NNS for_IN greater_JJR than_IN 95_CD %_NN of_IN ethanol_NN removal_NN ,_, it_PRP is_VBZ
          assumed_VBN that_IN the_DT liver_NN is_VBZ the_DT only_JJ site_NN of_IN ethanol_NN
          elimination_NN [_NN 19_CD ]_NN ._. The_DT liver_NN metabolic_JJ constants_NNS (_( Vm_NNP =_SYM
          2_CD ._. 1_CD millimoles_NNS /_NN min_NN for_IN 80_CD Kg_NNP man_NN ,_, Km_NNP =_SYM 0_CD ._. 04_CD mM_NN )_) were_VBD
          adjusted_VBN using_VBG the_DT Powell_NNP minimization_NN procedure_NN of_IN
          PKQuest_NNP to_TO give_VB the_DT best_JJS fit_NN to_TO the_DT data_NNS ._. These_DT values_NNS
          refer_VBP to_TO the_DT free_JJ water_NN concentration_NN in_IN the_DT liver_NN (_( see_VB [_NN
          5_CD ]_NN for_IN details_NNS )_) ._. There_EX are_VBP a_DT number_NN of_IN isoenzymes_NNS of_IN
          alcohol_NN dehyrogrenase_NN (_( ADH_NNP )_) in_IN the_DT human_JJ liver_NN and_CC this_DT
          model_JJ Km_NNP of_IN 0_CD ._. 04_CD mM_NN is_VBZ consistent_JJ with_IN the_DT in_IN vitro_NN Km_NNP of_IN
          0_CD ._. 048_CD mM_NN observed_VBD for_IN one_CD of_IN these_DT isoenzyme_NN [_NN 20_CD ]_NN ._. It_PRP
          is_VBZ assumed_VBN that_DT ethanol_NN distributes_VBZ in_IN the_DT total_JJ body_NN
          water_NN ,_, which_WDT is_VBZ the_DT default_NN in_IN PKQuest_NNP ._. The_DT parameter_NN fw_NN
          [_NN lipid_NN ]_NN =_SYM 1_CD /_NN 0_CD ._. 074_CD represents_VBZ the_DT inverse_NN of_IN the_DT oil_NN /_NN water_NN
          partition_NN coefficient_NN and_CC indicates_VBZ that_IN the_DT equilibrium_NN
          ethanol_NN concentration_NN in_IN the_DT body_NN fat_NN is_VBZ 7_CD ._. 4_CD %_NN of_IN the_DT
          concentration_NN in_IN body_NN water_NN [_NN 21_CD ]_NN ._. The_DT ethanol_NN dose_NN was_VBD
          0_CD ._. 4_CD gm_NN /_NN Kg_NNP ,_, given_VBN as_IN a_DT constant_JJ 30_CD minute_NN infusion_NN ,_,
          corresponding_JJ to_TO an_DT infusion_NN rate_NN of_IN 23_CD ._. 15_CD millimoles_NNS /_NN min_NN
          for_IN an_DT 80_CD Kg_NNP human_NN ._. This_DT Maple_NNP procedure_NN
          (_( ethanol_NN __NN norberg_NN )_) completely_RB specifies_VBZ the_DT PBPK_NNP
          parameters_NNS ._. All_DT the_DT other_JJ model_NN parameters_NNS are_VBP set_VBN by_IN the_DT
          calls_NNS to_TO defaultpar_NN (_( )_) and_CC standardhuman_NN (_( )_) ._. Figure_NN 2_CD shows_VBZ
          the_DT output_NN of_IN PKQuest_NNP for_IN this_DT input_NN ._. Again_RB ,_, the_DT
          agreement_NN between_IN the_DT PBPK_NNP prediction_NN for_IN the_DT arterial_NN
          blood_NN concentration_NN (_( solid_JJ line_NN )_) and_CC the_DT observed_VBN breath_NN
          data_NNS (_( squares_NNS )_) is_VBZ quite_RB good_JJ ._.
        
        
          Quantitation_NNP of_IN ethanol_NN first_RB pass_NN metabolism_NN
          (_( FPM_NNP )_)
          DiPadova_NNP et_CC al_NN ._. [_NN 17_CD ]_NN measured_VBD the_DT blood_NN ethanol_NN in_IN
          subjects_NNS that_WDT were_VBD given_VBN the_DT same_JJ dose_NN of_IN ethanol_NN ,_, either_CC
          IV_NNP (_( 20_CD minute_NN constant_JJ infusion_NN )_) or_CC orally_RB (_( over_IN 10_CD
          minutes_NNS )_) ,_, on_IN consecutive_JJ days_NNS ._. Figure_NN 3_CD shows_VBZ the_DT venous_JJ
          concentrations_NNS as_IN a_DT function_NN of_IN time_NN when_WRB a_DT low_JJ dose_NN of_IN
          ethanol_NN (_( 0_CD ._. 15_CD g_SYM /_NN Kg_NNP ,_, equivalent_JJ to_TO approximately_RB 12_CD oz_NN of_IN
          beer_NN )_) was_VBD given_VBN at_IN the_DT same_JJ time_NN as_IN a_DT standard_JJ breakfast_NN
          either_CC IV_NNP (_( black_JJ )_) or_CC orally_RB (_( red_JJ )_) ._. The_DT area_NN under_IN the_DT
          oral_JJ dose_NN curve_NN is_VBZ only_RB 27_CD %_NN of_IN that_DT for_IN the_DT IV_NNP dose_NN ._. This_DT
          would_MD correspond_VB to_TO a_DT FPM_NNP of_IN 73_CD %_NN if_IN metabolism_NN was_VBD linear_JJ
          -_: i_NNP ._. e_SYM ._. only_RB 27_CD %_NN of_IN the_DT orally_RB ingested_JJ ethanol_NN reaches_VBZ
          the_DT systemic_JJ circulation_NN ._. ._. As_IN will_MD be_VB shown_VBN below_IN ,_, the_DT
          actual_JJ FPM_NNP is_VBZ much_RB less_JJR than_IN this_DT ._.
          The_DT data_NNS in_IN fig_NN ._. 3_LS was_VBD analyzed_VBN using_VBG PKQuest_NNP ._. Figure_NN
          4_CD Ashows_NNP the_DT agreement_NN between_IN the_DT PBPK_NNP model_NN and_CC the_DT
          venous_JJ plasma_NN ethanol_NN concentration_NN for_IN the_DT IV_NNP input_NN
          data_NNS ._. The_DT PBPK_NNP parameters_NNS used_VBN in_IN this_DT calculation_NN were_VBD
          identical_JJ to_TO those_DT used_VBN for_IN figure_NN 2_CD except_IN that_IN the_DT
          portal_NN blood_NN flow_NN was_VBD increased_VBD 50_CD %_NN because_IN of_IN the_DT
          coincident_JJ meal_NN [_NN 22_CD 23_CD 24_CD ]_NN ,_, the_DT liver_NN Vm_NNP was_VBD increased_VBN
          from_IN 2_CD ._. 1_CD to_TO 2_CD ._. 5_CD because_IN of_IN the_DT induced_VBN ethanol_NN effect_NN [_NN
          25_CD 26_CD ]_NN and_CC the_DT muscle_NN blood_NN flow_NN was_VBD doubled_VBN ._. Also_RB ,_, the_DT
          parameter_NN "_'' concunit_NN [_NN vein_NN ]_NN "_'' was_VBD set_VBN =_SYM 2_CD ,_, indicating_VBG that_IN
          the_DT whole_JJ blood_NN venous_JJ concentration_NN was_VBD used_VBN as_IN the_DT
          input_NN data_NN ._.
          Figure_NN 4_CD Bshows_NNP the_DT output_NN of_IN PKQuest_NNP when_WRB the_DT
          "_'' findabsorption_NN "_'' [_NN 5_CD ]_NN option_NN was_VBD applied_VBN to_TO the_DT oral_JJ
          ethanol_NN input_NN data_NNS ._. Since_IN the_DT IV_NNP and_CC oral_JJ data_NNS used_VBN for_IN
          figs_NNS ._. 4_LS Aand_NNP 4_CD Bwere_NNP collected_VBD in_IN the_DT same_JJ subjects_NNS under_IN
          identical_JJ conditions_NNS ,_, exactly_RB the_DT same_JJ PBPK_NNP parameters_NNS
          where_WRB used_VBN for_IN both_DT calculations_NNS ._. The_DT open_JJ squares_NNS show_VBP
          the_DT time_NN course_NN of_IN the_DT predicted_VBN GI_NNP ethanol_NN absorption_NN
          (_( amount_NN entering_VBG the_DT liver_NN in_IN the_DT portal_NN vein_NN [_NN 5_CD ]_NN )_) ._.
          The_DT solid_JJ line_NN is_VBZ a_DT 3_CD parameter_NN approximation_NN to_TO the_DT
          absorption_NN data_NN (_( absorption_NN at_IN time_NN t_NN =_SYM A_DT [_NN t_NN H_NNP /_NN (_( t_NN H_NNP +_NN T_NN H_NNP )_) ]_NN
          where_WRB A_DT =_SYM total_JJ absorption_NN ,_, H_NNP =_SYM Hill_NNP exponent_NN ,_, T_NN =_SYM half_JJ
          time_NN )_) ._.
          It_PRP can_MD be_VB seen_VBN that_IN the_DT intestinal_NN absorption_NN (_( fig_NN ._.
          4_LS B_NNP )_) is_VBZ complete_JJ within_IN about_IN 2_CD hours_NNS ._. The_DT total_NN predicted_VBD
          absorption_NN of_IN 250_CD millimoles_NNS is_VBZ slightly_RB less_JJR than_IN the_DT
          actual_JJ total_JJ oral_JJ dose_NN of_IN 260_CD millimoles_NNS ._. Although_IN this_DT
          is_VBZ consistent_JJ with_IN a_DT small_JJ amount_NN of_IN gastric_JJ mucosal_NN
          metabolism_NN (_( 10_CD millimoles_NNS )_) it_PRP is_VBZ probably_RB not_RB
          significant_JJ ._. The_DT calculation_NN of_IN the_DT total_JJ absorption_NN for_IN
          this_DT low_JJ dose_NN is_VBZ critically_RB dependent_JJ on_IN the_DT accuracy_NN of_IN
          the_DT venous_JJ blood_NN measurements_NNS at_IN long_JJ times_NNS ._. Since_IN the_DT
          liver_NN has_VBZ such_JJ a_DT low_JJ Km_NNP (_( 0_CD ._. 04_CD mM_NN )_) ,_, significant_JJ amounts_NNS of_IN
          intestinal_NN absorption_NN could_MD be_VB occurring_VBG at_IN long_JJ times_NNS
          even_RB though_IN the_DT venous_JJ concentration_NN remained_VBD close_RB to_TO
          zero_CD because_IN of_IN the_DT high_JJ rate_NN of_IN liver_NN clearance_NN ._. The_DT
          fluctuation_NN in_IN the_DT total_JJ absorption_NN points_NNS at_IN long_JJ times_NNS
          in_IN fig_NN ._. 4_LS Bis_NNP caused_VBN by_IN errors_NNS in_IN these_DT long_JJ time_NN blood_NN
          measurements_NNS ._.
          When_WRB the_DT "_'' findabsorption_NN "_'' option_NN is_VBZ used_VBN ,_, PKQuest_NNP also_RB
          routinely_RB calculates_VBZ the_DT time_NN course_NN of_IN the_DT "_'' Peripheral_NNP
          Availability_NNP "_'' (_( PA_NNP )_) ,_, indicated_VBN by_IN the_DT diamonds_NNS in_IN fig_NN ._.
          4_LS BThe_NNP PA_NNP is_VBZ defined_VBN as_IN the_DT equivalent_JJ IV_NNP input_NN that_WDT would_MD
          produce_VB the_DT observed_VBD venous_JJ concentration_NN ._. Thus_RB ,_, an_DT IV_NNP
          input_NN with_IN the_DT time_NN course_NN of_IN the_DT diamonds_NNS in_IN fig_NN ._.
          4_LS Bwould_NNP produce_VB exactly_RB the_DT same_JJ blood_NN concentration_NN as_IN a_DT
          function_NN of_IN time_NN as_IN the_DT GI_NNP absorption_NN represented_VBN by_IN the_DT
          open_JJ squares_NNS ._. PA_NNP is_VBZ related_VBN to_TO FPM_NNP by_IN the_DT relation_NN :_: FPM_NNP =_SYM
          Total_NNP Dose_NNP -_: PA_NNP ._. Thus_RB for_IN the_DT data_NNS used_VBN for_IN fig_NN ._. 4_LS B_NNP ,_, the_DT
          PA_NNP of_IN 160_CD millimoles_NNS corresponds_NNS to_TO a_DT FPM_NNP of_IN 100_CD
          millimoles_NNS (_( total_JJ dose_NN =_SYM 260_CD )_) ._. This_DT represents_VBZ 38_CD %_NN of_IN the_DT
          total_JJ dose_NN ,_, about_IN half_PDT the_DT value_NN of_IN 73_CD %_NN using_VBG the_DT
          classical_JJ AUC_NNP approach_NN ._.
          The_DT FPM_NNP for_IN this_DT data_NNS was_VBD also_RB estimated_VBN by_IN using_VBG the_DT
          one_CD compartment_NN approach_NN [_NN 3_CD ]_NN ._. Figure_NN 5_CD Ashows_NNP the_DT
          optimized_JJ one_CD compartment_NN Michaelis-_NNP Menten_NNP fit_VBP to_TO the_DT
          tail_NN of_IN the_DT venous_JJ ethanol_NN data_NNS (_( Vm_NNP =_SYM 8_CD ._. 68_CD
          millimoles_NNS /_NN min_NN ;_: Km_NNP =_SYM 5_CD ._. 46_CD mM_NN )_) ._. Figure_NN 5_CD Bshows_NNP the_DT
          corresponding_JJ fit_NN to_TO the_DT data_NNS of_IN DiPadova_NNP etal_NN ._. [_NN 17_CD ]_NN
          for_IN a_DT doubling_VBG (_( 0_CD ._. 3_LS gm_NN /_NN Kg_NNP )_) of_IN the_DT oral_JJ dose_NN (_( see_VB below_IN )_) ._.
          Not_RB surprisingly_RB ,_, a_DT one_CD compartment_NN model_NN does_VBZ not_RB
          provide_VB an_DT accurate_JJ fit_NN to_TO the_DT ethanol_NN data_NN ._. The_DT fit_NN is_VBZ
          better_JJR for_IN the_DT large_JJ input_NN dose_NN ._. Using_VBG these_DT values_NNS of_IN Vm_NNP
          and_CC Km_NNP ,_, the_DT PA_NNP was_VBD determined_VBN for_IN the_DT IV_NNP and_CC oral_JJ dose_NN by_IN
          assuming_VBG a_DT one_CD compartment_NN model_NN and_CC integrating_VBG the_DT
          liver_NN metabolism_NN (_( =_SYM VmC_NNP /_NN (_( Km_NNP +_NN C_NNP )_) where_WRB C_NNP equals_VBZ venous_JJ
          blood_NN concentration_NN )_) over_IN the_DT time_NN ._. For_IN the_DT data_NNS of_IN fig_NN ._.
          4_LS ,_, this_DT one_CD compartment_NN method_NN yielded_VBD a_DT FPM_NNP of_IN 59_CD %_NN ._. This_DT
          is_VBZ less_JJR than_IN the_DT 73_CD %_NN estimated_VBN from_IN the_DT AUC_NNP ,_, but_CC
          significantly_RB greater_JJR than_IN the_DT 38_CD %_NN using_VBG PKQuest_NNP ._.
          DiPadova_NNP et_CC al_NN ._. [_NN 17_CD ]_NN also_RB measured_VBD the_DT blood_NN levels_NNS
          resulting_VBG from_IN an_DT IV_NNP or_CC oral_JJ input_NN of_IN a_DT larger_JJR ethanol_NN
          dose_NN (_( 0_CD ._. 3_LS gm_NN /_NN Kg_NNP ,_, total_JJ dose_NN of_IN 520_CD millimoles_NNS for_IN the_DT 80_CD
          Kg_NNP model_NN subject_JJ )_) and_CC this_DT time_NN they_PRP also_RB compared_VBD the_DT
          fasting_VBG and_CC standard_JJ breakfast_NN case_NN ._. Figures_NNS 6_CD Aand_NNP 6_CD Bshow_NNP
          the_DT PKQuest_NNP output_NN for_IN the_DT IV_NNP and_CC oral_JJ data_NNS when_WRB the_DT
          ethanol_NN was_VBD taken_VBN with_IN the_DT same_JJ standard_JJ meal_NN as_IN was_VBD used_VBN
          for_IN the_DT data_NNS in_IN figs_NNS ._. 4_LS Aand_NNP 4_CD B_NNP ._. The_DT parameters_NNS were_VBD
          identical_JJ to_TO those_DT used_VBN in_IN figs_NNS ._. 4_LS except_IN that_IN the_DT liver_NN
          Vm_NNP was_VBD reduced_VBN from_IN 2_CD ._. 5_CD to_TO 2_CD ._. 4_CD (_( a_DT different_JJ set_NN of_IN
          subjects_NNS were_VBD used_VBN in_IN the_DT two_CD sets_NNS of_IN experiments_NNS )_) ._. It_PRP
          can_MD be_VB seen_VBN from_IN fig_NN ._. 6_CD Bthat_NNP ,_, for_IN this_DT higher_JJR dose_NN ,_, the_DT
          total_JJ peripheral_JJ availability_NN (_( diamonds_NNS )_) is_VBZ only_RB about_IN 40_CD
          millimoles_NNS less_JJR than_IN the_DT total_JJ dose_NN of_IN 520_CD millimoles_NNS ,_,
          corresponding_JJ to_TO a_DT fractional_JJ FPM_NNP of_IN 7_CD %_NN ._. This_DT is_VBZ much_RB
          less_JJR than_IN the_DT FPM_NNP value_NN of_IN 44_CD %_NN determined_VBN by_IN using_VBG the_DT
          AUC_NNP approach_NN or_CC of_IN 30_CD %_NN using_VBG the_DT one_CD compartment_NN
          approach_NN ._. The_DT time_NN course_NN of_IN the_DT intestinal_NN absorption_NN
          for_IN the_DT two_CD doses_NNS (_( compare_VB fig_NN ._. 4_LS Band_NNP fig_NN ._. 6_CD B_NNP )_) has_VBZ the_DT
          same_JJ shape_NN (_( e_SYM ._. g_SYM ._. same_JJ Hill_NNP coefficient_NN )_) but_CC occurs_VBZ over_IN a_DT
          slightly_RB longer_JJR time_NN for_IN the_DT larger_JJR dose_NN (_( Hill_NNP half_JJ time_NN
          =_SYM 34_CD minutes_NNS for_IN 0_CD ._. 15_CD gm_NN /_NN Kg_NNP dose_NN ,_, and_CC 48_CD minutes_NNS for_IN 0_CD ._. 3_CD
          gm_NN /_NN Kg_NNP dose_NN )_) presumably_RB because_IN the_DT larger_JJR oral_JJ dose_NN was_VBD
          ingested_JJ over_IN a_DT longer_JJR time_NN (_( 20_CD minutes_NNS for_IN 0_CD ._. 3_CD gm_NN /_NN Kg_NNP
          versus_CC 10_CD minutes_NNS for_IN 0_CD ._. 15_CD gm_NN /_NN Kg_NNP )_) ._.
          Figures_NNS 7_CD Aand_NNP 7_CD Bshow_NNP the_DT PKQuest_NNP output_NN for_IN the_DT same_JJ
          ethanol_NN dose_NN (_( 0_CD ._. 3_LS gm_NN /_NN Kg_NNP )_) given_VBN to_TO fasting_VBG subjects_NNS ._. The_DT
          PBPK_NNP parameters_NNS for_IN these_DT experiments_NNS had_VBD the_DT portal_NN
          blood_NN flow_NN reduced_VBN back_RB to_TO the_DT default_NN fasting_VBG value_NN ._.
          Also_RB ,_, the_DT liver_NN Vm_NNP was_VBD reduced_VBN back_RB to_TO 2_CD ._. 0_CD ,_, the_DT same_JJ
          value_NN that_WDT was_VBD used_VBN for_IN the_DT fasting_VBG data_NN of_IN Norberg_NNP et_CC al_NN
          [_NN 16_CD ]_NN in_IN fig_NN 2_CD ._. This_DT change_NN in_IN ethanol_NN metabolism_NN is_VBZ
          consistent_JJ with_IN earlier_JJR observations_NNS that_IN the_DT rate_NN of_IN
          ethanol_NN disappearance_NN from_IN the_DT blood_NN is_VBZ increased_VBN by_IN a_DT
          coincident_JJ meal_NN [_NN 25_CD 26_CD ]_NN ._. It_PRP can_MD be_VB seen_VBN in_IN fig_NN ._. 7_CD Bthat_NNP
          the_DT PA_NNP (_( diamonds_NNS )_) is_VBZ nearly_RB identical_JJ to_TO the_DT GI_NNP
          absorption_NN (_( squares_NNS )_) so_IN that_IN FPM_NNP is_VBZ close_JJ to_TO zero_CD for_IN the_DT
          fasting_VBG subjects_NNS ._. The_DT AUC_NNP and_CC one_CD compartment_NN approach_NN
          also_RB indicate_VBP a_DT small_JJ FPM_NNP for_IN this_DT case_NN ._.
        
      
      
        Discussion_NNP and_CC conclusions_NNS
        
          Validity_NNP of_IN the_DT PBPK_NNP model_NN
          The_DT philosophy_NN behind_IN the_DT use_NN and_CC development_NN of_IN
          PKQuest_NNP differs_VBZ from_IN that_DT of_IN the_DT standard_JJ PBPK_NNP
          applications_NNS ._. PBPK_NNP models_NNS have_VBP usually_RB been_VBN applied_VBN to_TO
          animal_NN data_NNS where_WRB it_PRP is_VBZ possible_JJ to_TO accurately_RB measure_VB
          and_CC control_VB the_DT relevant_JJ parameters_NNS (_( tissue_NN distribution_NN ,_,
          organ_NN blood_NN flows_NNS ,_, etc_FW ._. )_) ._. In_IN contrast_NN ,_, for_IN human_JJ studies_NNS ,_,
          not_RB only_RB are_VBP the_DT PBPK_NNP parameters_NNS poorly_RB characterized_VBN ,_,
          but_CC they_PRP are_VBP subject_JJ to_TO large_JJ individual_JJ variation_NN ._. The_DT
          impetus_NN behind_IN PKQuest_NNP is_VBZ to_TO try_VB and_CC develop_VB a_DT "_'' standard_JJ "_''
          set_NN of_IN human_JJ PBPK_NNP parameters_NNS that_WDT can_MD be_VB applied_VBN in_IN the_DT
          absence_NN of_IN this_DT detailed_VBN information_NN ._. For_IN this_DT reason_NN ,_,
          the_DT application_NN of_IN PKQuest_NNP to_TO human_JJ data_NNS should_MD be_VB
          regarded_VBN as_IN a_DT first_JJ approximation_NN ._.
          Since_IN muscle_NN represents_VBZ roughly_RB 50_CD %_NN of_IN the_DT body_NN mass_NN ,_,
          the_DT muscle_NN blood_NN flow_NN ,_, which_WDT can_MD vary_VB 10_CD fold_VB or_CC more_JJR
          depending_VBG on_IN experimental_JJ conditions_NNS ,_, is_VBZ the_DT single_JJ most_RBS
          important_JJ PBPK_NNP parameter_NN and_CC the_DT parameter_NN that_IN limits_VBZ
          the_DT accuracy_NN of_IN the_DT PBPK_NNP model_NN ._. The_DT pharmacokinetics_NNS of_IN D_NNP
          
          2_LS O_NNP (_( or_CC other_JJ tracers_NNS of_IN water_NN )_) are_VBP
          especially_RB simple_JJ since_IN the_DT rate_NN of_IN elimination_NN is_VBZ very_RB
          slow_JJ and_CC it_PRP distributes_VBZ simply_RB in_IN the_DT organ_NN water_NN ._. As_IN
          shown_VBN by_IN figs_NNS ._. 1_LS Aand_NNP 1_CD B_NNP ,_, the_DT D_NNP 
          2_CD O_NNP kinetics_NNS are_VBP sensitive_JJ to_TO the_DT
          muscle_NN blood_NN flow_NN and_CC the_DT data_NNS of_IN Schloerb_NNP et_CC al_NN ._. [_NN 15_CD ]_NN
          was_VBD used_VBN to_TO determine_VB the_DT resting_VBG muscle_NN blood_NN flow_NN value_NN
          (_( 0_CD ._. 0266_CD liters_NNS /_NN min_NN /_NN Kg_NNP )_) for_IN the_DT "_'' standardhuman_NN "_'' ._. Although_IN
          it_PRP is_VBZ problematical_JJ to_TO base_VB such_JJ an_DT important_JJ parameter_NN
          on_IN just_RB one_CD set_NN of_IN measurements_NNS on_IN one_CD subject_JJ ,_, this_DT
          represents_VBZ the_DT only_RB published_VBN measurement_NN of_IN this_DT type_NN
          that_IN I_PRP could_MD find_VB ._. It_PRP is_VBZ also_RB an_DT approximation_NN to_TO treat_VB
          the_DT muscle_NN as_IN a_DT single_JJ compartment_NN with_IN a_DT uniform_NN blood_NN
          flow_NN and_CC in_IN some_DT human_JJ PBPK_NNP models_NNS [_NN 27_CD ]_NN two_CD muscle_NN
          compartments_NNS (_( "_'' resting_VBG "_'' and_CC "_'' working_VBG "_'' )_) are_VBP included_VBN ._. For_IN
          the_DT PKQuest_NNP modeling_NN ,_, the_DT muscle_NN blood_NN flow_NN is_VBZ usually_RB
          treated_VBN as_IN an_DT adjustable_JJ parameter_NN and_CC not_RB as_IN a_DT strictly_RB
          determined_VBN PBPK_NNP constant_JJ ._.
          The_DT ethanol_NN data_NN that_WDT was_VBD modeled_VBN are_VBP the_DT mean_NN values_NNS ,_,
          averaged_VBD over_IN a_DT number_NN of_IN individuals_NNS ._. Because_IN of_IN the_DT
          non-linear_JJ nature_NN of_IN the_DT pharmacokinetics_NNS ,_, it_PRP is_VBZ an_DT
          approximation_NN to_TO treat_VB these_DT mean_NN values_NNS as_IN
          representative_NN of_IN an_DT equivalent_NN "_'' average_JJ "_'' human_JJ [_NN 28_CD ]_NN ._.
          However_RB ,_, it_PRP should_MD provide_VB a_DT first_JJ approximation_NN to_TO the_DT
          PBPK_NNP parameters_NNS of_IN an_DT "_'' average_JJ "_'' human_JJ ._. For_IN the_DT common_JJ
          case_NN where_WRB the_DT published_VBN mean_NN values_NNS are_VBP the_DT only_JJ data_NN
          that_WDT is_VBZ available_JJ ,_, there_EX is_VBZ no_DT other_JJ option_NN ._.
          In_IN the_DT PKQuest_NNP modeling_NN of_IN ethanol_NN ,_, it_PRP is_VBZ assumed_VBN that_DT
          ethanol_NN distributes_VBZ freely_RB in_IN the_DT tissue_NN water_NN ._. This_DT
          seems_VBZ like_IN a_DT reasonable_JJ assumption_NN given_VBN the_DT
          physical-chemical_JJ properties_NNS of_IN ethanol_NN ._. Measurements_NNP of_IN
          plasma_NN /_NN whole_JJ blood_NN concentration_NN ratios_NNS show_VBP that_IN this_DT
          assumption_NN is_VBZ valid_JJ for_IN red_JJ blood_NN cells_NNS [_NN 29_CD ]_NN ._. However_RB ,_,
          Norberg_NNP et_CC al_NN ._. [_NN 16_CD 19_CD ]_NN has_VBZ shown_VBN that_IN the_DT ethanol_NN
          volume_NN of_IN distribution_NN estimated_VBD using_VBG a_DT 2_CD compartment_NN
          model_NN is_VBZ significantly_RB less_JJR than_IN the_DT total_JJ water_NN volume_NN
          and_CC they_PRP have_VBP reviewed_VBN the_DT literature_NN that_WDT suggests_VBZ that_IN
          the_DT tissue_NN ethanol_NN distribution_NN may_MD be_VB restricted_VBN ._.
          Despite_IN this_DT ,_, the_DT agreement_NN between_IN PKQuest_NNP results_NNS and_CC
          the_DT Norberg_NNP et_CC al_NN ._. data_NNS (_( figure_NN 2_LS )_) indicate_VBP that_IN this_DT
          assumption_NN is_VBZ a_DT useful_JJ approximation_NN given_VBN the_DT
          limitations_NNS of_IN using_VBG the_DT mean_NN data_NN ._.
        
        
          Ethanol_NNP first_JJ pass_NN metabolism_NN and_CC intestinal_NN
          absorption_NN
          The_DT definition_NN of_IN FPM_NNP implemented_VBD in_IN PKQuest_NNP is_VBZ both_DT
          rigorous_JJ and_CC intuitive_JJ ._. It_PRP is_VBZ based_VBN on_IN defining_VBG a_DT time_NN

          dependent_JJ "_'' peripheral_JJ availability_NN "_'' (_( PA_NNP )_) that_WDT is_VBZ equal_JJ to_TO
          the_DT rate_NN of_IN IV_NNP input_NN that_WDT would_MD produce_VB the_DT observed_VBN time_NN
          course_NN of_IN the_DT plasma_NN ethanol_NN concentration_NN ._. This_DT PA_NNP is_VBZ a_DT
          direct_JJ quantitative_JJ measure_NN of_IN the_DT amount_NN of_IN ethanol_NN that_WDT
          has_VBZ reached_VBN the_DT systemic_JJ circulation_NN ._. The_DT FPM_NNP is_VBZ then_RB
          defined_VBN as_IN the_DT difference_NN between_IN the_DT total_JJ dose_NN
          administered_VBN and_CC the_DT PA_NNP ._. The_DT classical_JJ procedure_NN of_IN
          determining_VBG FPM_NNP from_IN the_DT AUC_NNP (_( eq_NN ._. 1_LS )_) markedly_RB
          overestimates_NNS the_DT FPM_NNP ._. For_IN the_DT case_NN of_IN the_DT small_JJ ethanol_NN
          dose_NN (_( 0_CD ._. 15_CD gm_NN /_NN Kg_NNP )_) taken_VBN with_IN a_DT meal_NN ,_, the_DT AUC_NNP estimate_NN of_IN
          fractional_JJ FPM_NNP of_IN 73_CD %_NN was_VBD about_IN twice_RB the_DT value_NN (_( 38_CD %_NN )_)
          obtained_VBN using_VBG PKQuest_NNP ._. For_IN the_DT higher_JJR dose_NN (_( 0_CD ._. 3_LS gm_NN /_NN Kg_NNP )_)
          the_DT error_NN was_VBD even_RB larger_JJR (_( 44_CD %_NN versus_CC 7_CD %_NN )_) ._. Although_IN the_DT
          more_RBR recent_JJ one_CD compartment_NN approximation_NN provides_VBZ a_DT
          better_JJR estimate_NN of_IN FPM_NNP ,_, it_PRP is_VBZ still_RB significantly_RB larger_JJR
          than_IN the_DT PKQuest_NNP values_NNS (_( 59_CD %_NN versus_CC 38_CD %_NN for_IN 0_CD ._. 15_CD gm_NN /_NN Kg_NNP
          dose_NN and_CC 30_CD %_NN versus_CC 7_CD %_NN for_IN 0_CD ._. 3_CD gm_NN /_NN Kg_NNP dose_NN )_) ._.
          The_DT error_NN in_IN both_DT these_DT approximations_NNS to_TO FPM_NNP results_NNS
          primarily_RB from_IN the_DT fact_NN that_IN the_DT systemic_JJ appearance_NN of_IN
          the_DT oral_JJ ethanol_NN taken_VBN with_IN a_DT meal_NN is_VBZ slow_JJ compared_VBN to_TO
          the_DT 20_CD minute_NN constant_JJ infusion_NN that_WDT was_VBD used_VBN to_TO obtain_VB
          the_DT IV_NNP AUC_NNP ._. Since_IN the_DT liver_NN ethanol_NN metabolism_NN saturates_NNS
          at_IN low_JJ concentrations_NNS ,_, the_DT shorter_JJR dose_NN will_MD have_VB a_DT
          higher_JJR average_JJ blood_NN concentration_NN and_CC a_DT corresponding_JJ
          lower_JJR value_NN of_IN fractional_JJ metabolism_NN ._. The_DT error_NN would_MD be_VB
          less_JJR if_IN the_DT time_NN course_NN of_IN the_DT oral_JJ absorption_NN was_VBD
          similar_JJ to_TO that_DT of_IN the_DT IV_NNP input_NN ._. This_DT explains_VBZ why_WRB the_DT
          AUC_NNP calculated_VBD FPM_NNP [_NN 17_CD ]_NN was_VBD greatly_RB reduced_VBN when_WRB the_DT
          subjects_NNS were_VBD fasting_VBG so_IN that_IN the_DT gastric_JJ emptying_VBG rate_NN
          was_VBD increased_VBN and_CC GI_NNP absorption_NN was_VBD more_RBR rapid_JJ (_( compare_VB
          figs_NNS ._. 6_CD Band_NNP 7_CD B_NNP )_) and_CC closer_JJR to_TO the_DT rate_NN of_IN IV_NNP infusion_NN ._.
          The_DT critical_JJ dependence_NN of_IN the_DT AUC_NNP on_IN the_DT rate_NN of_IN
          systemic_JJ ethanol_NN input_NN was_VBD first_RB pointed_VBD out_IN by_IN Wagner_NNP [_NN
          30_CD ]_NN ._. He_PRP showed_VBD that_IN the_DT AUC_NNP for_IN the_DT oral_JJ input_NN was_VBD
          equal_JJ to_TO (_( or_CC even_RB larger_JJR than_IN )_) the_DT IV_NNP AUC_NNP if_IN the_DT IV_NNP
          infusion_NN was_VBD administered_VBN at_IN a_DT slower_JJR rate_NN (_( for_IN 2_CD hours_NNS )_)
          than_IN the_DT rate_NN of_IN intestinal_NN absorption_NN ._.
          Failure_NN to_TO appreciate_VB the_DT problems_NNS inherent_JJ in_IN using_VBG
          the_DT AUC_NNP or_CC one_CD compartment_NN method_NN to_TO measure_VB FPM_NNP has_VBZ led_VBN
          to_TO the_DT concept_NN that_IN the_DT gastric_JJ mucosa_NN metabolizes_NNS a_DT
          significant_JJ fraction_NN of_IN oral_JJ ethanol_NN ._. Lieber_NNP and_CC
          colleague_NN observed_VBD that_IN the_DT "_'' FPM_NNP "_'' was_VBD reduced_VBN when_WRB
          ethanol_NN was_VBD infused_VBN intraduodenally_RB compared_VBN to_TO the_DT
          standard_JJ oral_JJ administration_NN and_CC concluded_VBD that_IN the_DT
          difference_NN must_MD have_VB resulted_VBN from_IN gastric_JJ mucosa_NN
          metabolism_NN [_NN 6_CD 7_CD ]_NN ._. This_DT decreased_VBD FPM_NNP for_IN the_DT
          intradudenal_NN dose_NN is_VBZ probably_RB a_DT result_NN of_IN the_DT much_RB more_RBR
          rapid_JJ time_NN course_NN of_IN absorption_NN when_WRB the_DT ethanol_NN is_VBZ
          administered_VBN directly_RB into_IN the_DT duodenum_NN ._. PKQuest_NNP provides_VBZ
          a_DT direct_JJ estimate_NN of_IN the_DT amount_NN of_IN ethanol_NN reaching_VBG the_DT
          liver_NN ._. As_IN shown_VBN by_IN figs_NNS ._. 4_LS B_NNP ,_, 6_CD Band_NNP 7_CD B_NNP ,_, the_DT total_JJ amount_NN
          of_IN absorbed_VBN ethanol_NN reaching_VBG the_DT liver_NN does_VBZ not_RB differ_VB
          significantly_RB from_IN the_DT total_JJ oral_JJ dose_NN ,_, indicating_VBG that_IN
          gastric_JJ mucosa_NN metabolism_NN is_VBZ negligible_JJ ._.
          In_IN addition_NN to_TO providing_VBG a_DT direct_JJ measure_NN of_IN PA_NNP and_CC
          FPM_NNP ,_, PKQuest_NNP also_RB provides_VBZ ,_, for_IN the_DT first_JJ time_NN ,_,
          quantitative_JJ information_NN about_IN the_DT rate_NN of_IN intestinal_NN
          absorption_NN of_IN an_DT orally_RB administered_VBN drug_NN that_WDT has_VBZ
          non-linear_JJ metabolism_NN ._. A_DT comparison_NN of_IN figs_NNS ._. 6_CD Band_NNP
          7_CD Bprovides_NNP a_DT dramatic_JJ view_NN of_IN the_DT decreased_VBN rate_NN of_IN
          ethanol_NN absorption_NN when_WRB it_PRP is_VBZ accompanied_VBN by_IN a_DT meal_NN ._. In_IN
          the_DT fasting_VBG state_NN ,_, ethanol_NN is_VBZ almost_RB completely_RB absorbed_VBN
          within_IN 50_CD minutes_NNS (_( fig_NN ._. 7_CD B_NNP )_) while_IN the_DT ethanol_NN
          administered_VBN with_IN a_DT standard_JJ breakfast_NN takes_VBZ 3_CD or_CC more_JJR
          hours_NNS for_IN complete_JJ absorption_NN (_( fig_NN ._. 6_CD B_NNP )_) ._. Levitt_NNP et_CC al_NN ._. [_NN
          31_CD ]_NN simultaneously_RB measured_VBD the_DT rate_NN of_IN human_JJ gastric_JJ
          emptying_VBG and_CC ethanol_NN blood_NN concentration_NN with_IN and_CC without_IN
          a_DT meal_NN and_CC concluded_VBD that_IN the_DT rate_NN of_IN ethanol_NN absorption_NN
          was_VBD primarily_RB limited_VBN by_IN the_DT rate_NN of_IN gastric_JJ emptying_VBG ._.
          The_DT similarity_NN between_IN the_DT time_NN course_NN of_IN ethanol_NN
          absorption_NN seen_VBN in_IN figs_NNS ._. 6_CD Band_NNP 7_CD Band_NNP the_DT gastric_JJ emptying_VBG
          time_NN course_NN observed_VBN by_IN Levitt_NNP ,_, et_CC al_NN ._. [_NN 31_CD ]_NN supports_VBZ
          this_DT conclusion_NN ._.
        
        
          Simulation_NN of_IN ethanol_NN blood_NN levels_NNS after_IN oral_JJ
          intake_NN
          Another_DT feature_NN of_IN PKQuest_NNP is_VBZ that_IN it_PRP provides_VBZ a_DT
          simple_JJ interface_NN that_WDT can_MD be_VB used_VBN to_TO make_VB quantitative_JJ
          predictions_NNS of_IN the_DT blood_NN levels_NNS produced_VBN by_IN different_JJ
          oral_JJ doses_NNS ._. As_IN shown_VBN in_IN figs_NNS ._. 4_LS B_NNP ,_, 6_CD Band_NNP 7_CD B_NNP ,_, PKQuest_NNP
          routinely_RB fits_VBZ the_DT time_NN course_NN of_IN the_DT intestinal_NN
          absorption_NN with_IN a_DT 3_CD parameter_NN Hill_NNP type_NN equation_NN
          (_( Absorption_NNP at_IN time_NN t_NN =_SYM A_DT [_NN t_NN H_NNP /_NN (_( t_NN H_NNP +_NN T_NN H_NNP )_) ]_NN where_WRB A_DT =_SYM total_JJ
          absorption_NN ,_, H_NNP =_SYM Hill_NNP exponent_NN ,_, T_NN =_SYM half_JJ time_NN )_) ._. This_DT 3_CD
          parameter_NN input_NN function_NN can_MD then_RB be_VB used_VBN as_IN the_DT input_NN
          into_IN PKQuest_NNP ._. For_IN example_NN ,_, the_DT intestinal_NN absorption_NN
          input_NN function_NN that_WDT was_VBD determined_VBN for_IN the_DT 0_CD ._. 3_CD gm_NN /_NN Kg_NNP dose_NN
          of_IN ethanol_NN ingested_JJ with_IN a_DT meal_NN (_( see_VB fig_NN ._. 6_CD B_NNP )_) can_MD be_VB used_VBN
          for_IN a_DT model_NN simulation_NN using_VBG the_DT following_NN settings_NNS for_IN
          finput_NN :_:
          ninput_NN :_: =_SYM 1_CD ;_: findabs_NNS :_: =_SYM 0_CD ;_: finput_NN [_NN 1_CD ]_NN :_: =_SYM
          table_NN (_( [_NN organ_NN =_SYM liver_NN ,_, type_NN =_SYM 3_CD ,_, rate_NN =_SYM 524_CD ,_, tbeg_NN =_SYM 0_CD ,_,
          tend_VBP =_SYM 48_CD ._. 28_CD ,_, hn_NN =_SYM 1_CD ._. 87_CD ,_, csteady_NN =_SYM 0_CD
          This_DT corresponds_NNS to_TO a_DT total_JJ input_NN of_IN 524_CD millimoles_NNS
          into_IN the_DT portal_NN vein_NN (_( "_'' organ_NN =_SYM liver_NN "_'' )_) with_IN a_DT Hill_NNP
          coefficient_NN (_( "_'' hn_NN "_'' )_) of_IN 1_CD ._. 87_CD and_CC a_DT half_JJ time_NN (_( "_'' tend_VBP "_'' )_) of_IN
          48_CD ._. 28_CD minutes_NNS ._. Figure_NN 8_CD shows_VBZ that_IN the_DT simulated_JJ blood_NN
          level_NN for_IN this_DT input_NN function_NN (_( solid_JJ line_NN )_) slightly_RB
          underestimates_NNS the_DT peak_NN value_NN ,_, but_CC otherwise_RB is_VBZ in_IN good_JJ
          agreement_NN with_IN the_DT experimental_JJ data_NN (_( squares_NNS )_) that_WDT was_VBD
          used_VBN to_TO determine_VB this_DT input_NN function_NN ._. In_IN Figure_NN 9_CD this_DT
          feature_NN is_VBZ used_VBN to_TO illustrate_VB the_DT dramatic_JJ effect_NN of_IN a_DT
          concomitant_NN meal_NN on_IN the_DT blood_NN levels_NNS resulting_VBG from_IN an_DT
          oral_JJ intake_NN ._. The_DT figure_NN shows_VBZ the_DT blood_NN levels_NNS for_IN an_DT
          oral_JJ intake_NN of_IN 260_CD millimoles_NNS of_IN ethanol_NN (_( red_JJ line_NN ,_,
          roughly_RB equivalent_JJ to_TO one_CD 12_CD ounce_NN can_MD of_IN beer_NN )_) ;_: and_CC 2_CD
          (_( green_JJ )_) or_CC 3_CD (_( blue_JJ )_) times_NNS this_DT dose_NN ,_, all_DT ingested_JJ for_IN a_DT
          20_CD minute_NN time_NN period_NN either_CC with_IN (_( "_'' fed_VBN "_'' )_) or_CC without_IN
          (_( "_'' fasted_JJ "_'' )_) a_DT meal_NN ._. The_DT model_NN results_NNS for_IN the_DT "_'' fed_VBN "_'' case_NN
          (_( fig_NN ._. 9_CD ,_, left_VBD )_) used_VBD the_DT above_JJ rate_NN of_IN intestinal_NN
          absorption_NN determined_VBN from_IN the_DT data_NNS in_IN fig_NN ._. 6_CD B_NNP ._. The_DT
          "_'' fasted_JJ "_'' case_NN (_( fig_NN ._. 9_CD ,_, right_NN )_) used_VBD the_DT intestinal_NN
          absorption_NN rate_NN determined_VBN for_IN the_DT fasting_VBG data_NN in_IN fig_NN ._.
          7_CD B_NNP (_( Hill_NNP coefficient_NN =_SYM 2_CD ._. 6_CD ;_: half_JJ time_NN =_SYM 26_CD ._. 84_CD minutes_NNS )_) ._. In_IN
          addition_NN ,_, the_DT corresponding_JJ values_NNS of_IN liver_NN Vm_NNP and_CC portal_NN
          blood_NN flow_NN for_IN the_DT fed_VBN and_CC fasting_VBG conditions_NNS are_VBP used_VBN in_IN
          this_DT simulation_NN ._. The_DT influence_NN of_IN a_DT meal_NN on_IN ethanol_NN blood_NN
          levels_NNS is_VBZ especially_RB dramatic_JJ at_IN the_DT low_JJ intake_NN dose_NN ,_,
          decreasing_VBG the_DT peak_NN blood_NN level_NN by_IN about_IN 4_CD fold_VB ._.
        
      
      
        Competing_VBG interests_NNS
        None_NN declared_VBD ._.
      
    
  
